Your search returned 10 results.

Results
	1.	Evaluation of a simplified test for the rapid detection of antibody to the human immunodeficiency virus (HIV-1). [electronic resource] by Quinti, I Guerra, E Mezzaroma, I Scala, E Rainaldi, L Galluzzo, C M Aiuti, F Producer: 19911203 In: Allergologia et immunopathologia vol. 19 Availability: No items available. Save to lists Add to cart (remove)
	2.	HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trial. [electronic resource] by Floridia, M Fragola, V Galluzzo, C M Giannini, G Pirillo, M F Andreotti, M Tomino, C Vella, S Producer: 20020710 In: HIV medicine vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	HIV-1 coreceptor switch during 2 years of structured treatment interruptions. [electronic resource] by Baroncelli, S Galluzzo, C M Andreotti, M Pirillo, M F Fragola, V Weimer, L E Giuliano, M Vella, S Palmisano, L Producer: 20140805 In: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy. [electronic resource] by Palmisano, Lucia Giuliano, M Galluzzo, C M Amici, R Andreotti, M Weimer, L E Pirillo, M F Fragola, V Bucciardini, R Vella, S Producer: 20100721 In: HIV medicine vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL). [electronic resource] by Floridia, M Bucciardini, R Fragola, V Galluzzo, C M Giannini, G Pirillo, M F Amici, R Andreotti, M Ricciardulli, D Tomino, C Vella, S Producer: 20040607 In: HIV medicine vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Hospitalizations and costs of treatment for protease inhibitor-based regimens in patients with very advanced HIV-infection (CD4 < 50/mm(3)). [electronic resource] by Floridia, M Massella, M Bucciardini, R Perucci, C A Rossi, L Tomino, C Fragola, V Ricciardulli, D Galluzzo, C M Giannini, G Pirillo, M F Andreotti, M Mirra, M Vella, S Producer: 20011221 In: HIV clinical trials vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients. [electronic resource] by Bucciardini, R Wu, A W Floridia, M Fragola, V Ricciardulli, D Tomino, C Weimer, L E Pirillo, M F Mirra, M Marzi, M Giannini, G Galluzzo, C M Andreotti, M Massella, M Vella, S Producer: 20010614 In: AIDS (London, England) vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors. [electronic resource] by Bucciardini, R D'Ettorre, G Baroncelli, S Ceccarelli, G Parruti, G Weimer, L E Fragola, V Galluzzo, C M Pirillo, M F Lucattini, S Bellagamba, R Francisci, D Ladisa, N Degli Antoni, A Guaraldi, G Manconi, P E Vullo, V Preziosi, R Cirioni, O Verucchi, G Floridia, M Producer: 20130212 In: International journal of STD & AIDS vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease. [electronic resource] by Floridia, M Bucciardini, R Ricciardulli, D Fragola, V Pirillo, M F Weimer, L E Tomino, C Giannini, G Galluzzo, C M Andreotti, M Cargnel, A Alberici, F De Rienzo, B Leoncini, F Fiaccadori, F Francisci, D Grillone, W Ortona, L Piazza, M Scalzini, A Nigra, E Tumietto, F Vella, S Producer: 19990209 In: Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection. [electronic resource] by Floridia, M Tomino, C Bucciardini, R Ricciardulli, D Fragola, V Pirillo, M F Amici, R Giannini, G Galluzzo, C M Andreotti, M Seeber, A C Ammassari, A Cingolani, A Lazzarin, A Scalise, G Cargnel, A Suter, F Milazzo, F Pastore, G Moroni, M Ciammarughi, R Pini, R Carosi, G D'Amato, C Contu, L Concia, E Bonazzi, L Aiuti, F Vigevani, G Vella, S Producer: 20010412 In: AIDS research and human retroviruses vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)